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2-Nitroimidazole based fluorescent probes
for nitroreductase; monitoring reductive stress
in cellulo†
X. Ao,‡a S. A. Bright,‡b N. C. Taylorb and R. B. P. Elmes *a
Two 2-nitroimidazole-1,8-naphthalimide conjugates, 1 and 2, have
been synthesised as fluorescence probes for the detection of
reductive stress in HeLa cells. The 4-substituted derivative 1 was
shown to act as a highly sensitive and selective substrate for nitro-
reductase where it exhibited a clear blue to green ratiometric fluo-
rescence response visible to the naked eye. Moreover, biological
studies demonstrated 1 could be activated in cellulo where the
impact of reductive stress was easily monitored using confocal
microscopy and flow cytommetry.
Reactive oxygen species have long been known to play an
important physiological role in numerous diseases, and when
antioxidant defences are overwhelmed oxidative stress results.1
However, more recently, attention has been drawn to the oppo-
site situation, reductive stress, where the cellular environment
becomes more reduced than normal. Reductive stress, has also
been shown to play a pivotal role in numerous disease states
including, heart failure,2 Alzheimer’s disease3 and solid
tumors4 which are characterised by an increase in reducing
species such as reduced glutathione, reduced NADPH or an
increase in activation of oxidoreductase enzymes.5
Oxidoreductases such as nitroreductases (NTRs), are a particu-
larly valuable marker for reductive stress being capable of
reducing nitroaromatics to corresponding nitroso or amino
derivatives thereby converting an electron-withdrawing substi-
tuent in to an electron donating one; a feature that has been
exploited in both prodrug strategies6,7 and in methods for
selective detection of tumour hypoxia.8,9 However, despite
promising high levels of selectivity and sensitivity, in addition
to facile intracellular monitoring of NTR activity, the develop-
ment of fluorescent probes for NTR has only recently become
a burgeoning area of research interest.10 Indeed, a number of
research groups11–17 have recently published reports in this
emerging field of research where their approaches have often
taken advantage of various nitroaromatic ‘triggers’ such as
nitrobenzene, nitrofuran or nitrothiophene due to their rela-
tive ease of reduction.18–20 However, despite being widely used
in the development of bioreductive prodrugs, the 2-nitroimid-
azole functional group which is extremely sensitive to changes
in reductive stress,21,22 has not been considered in this
context.
With the overall aim of developing more sensitive fluo-
rescent probes for cellular reductive stress we set out to exploit
the 2-nitroimidazole moiety as a bioreductively responsive
‘trigger’ and synthesise two new fluorescently responsive NTR
sensors 1 and 2 based on the 1,8-naphthalimide fluorophore
(Fig. 1). Given the rich photophysical properties displayed by
1,8 naphthalimides, their observed biocompatibility,23–26 and
their dependence on the nature and location of any aryl
substituents,27–29 we envisaged that both 1 and 2 would, upon
reduction, give rise to a fragmentation of the parent molecule
and release of the well-known amino-1,8-naphthalimide
fluorophores (Fig. S8†). It was anticipated that the conversion
of the electron-withdrawing carbamate linker to the electron-
donating amino functional group would lead to significant
modulation of their optical properties and lead to a fluo-
rescence shift visible to the naked eye.
Herein, we report the synthesis and spectroscopic evalu-
ation of probes 1 and 2 (Fig. 1), varied in their attachment
Fig. 1 Chemical structures of the target NTR probes 1, 2 and NB.
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isation data, experimental details and figures relating to spectroscopic titrations
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position to the 2-nitroimidazole trigger, where we have shown
the 4-substituted derivative 1 to be a highly selective probe for
NTR. Moreover, we have also shown that, when compared to
the 4-nitrobenzyl substituted analogue NB (Fig. 1) the 2-nitro-
imidazole based probe 1 shows considerably increased sensi-
tivity to the NTR enzyme. We have also conducted biological
profiling of 1 where we have shown that it enters HeLa cells
rapidly by passive diffusion, is non-toxic and is amenable to
monitoring NTR facilitated reductive stress in mammalian
cells using both flow cytometry and confocal microscopy.
Sensors 1 and 2 were synthesized by the sequential reaction
of the appropriate amino-1,8-naphthalimide, 4 or 5 with the
2-nitroimidazole 3 to afford 1 and 2 in 68% and 63% yield,
respectively (Scheme S1†). The 2-nitroimidazole alcohol 3 was
synthesised according to a recently improved synthesis reported
by Conway et al.30 Briefly this consisted of formylation of sarco-
sine ethyl ester with subsequent treatment with cyanamide
under reflux in acetate-buffered conditions to yield a 2-amino-
imidazole derivative which was converted to the nitro function-
ality via diazotisation and NaBH4 mediated reduction of the
ester functionality to produce the desired alcohol 3. Nitrobenzyl
substituted analogue NB was synthesised in a similar manner
to 1 and 2 using 4-nitrobenzyl alcohol (see ESI†).
With 1 and 2 in hand, we evaluated their spectral character-
istics in phosphate buffered saline (PBS) (pH 7.4, 10 mM) with
0.5% DMSO as co-solvent where both 1 and 2 demonstrated
absorption and emission spectra characteristically different
from the respective amino-1,8-naphthalimide starting
materials 4 and 5. The absorption spectrum of 1 showed a λmax
at ca. 360 nm while 2 showed a λmax at ca. 345 nm along with a
broad shoulder centred at 390 nm. Upon excitation (λexc =
345 nm) 1 gave rise to emission with λmax at 475 nm while 2
(λexc = 345 nm) yielded emission with λmax ca. 460 nm,
however, with a lower emission intensity; a known character-
istic of 3-substituted-1,8-naphthalimides due to the unfavour-
able delocalisation of an internal charge transfer (ICT).27 The
design of 1 and 2 relies upon their ‘unmasking’ at the hands
of NTR to yield the corresponding amino-derivatives 4 and 5
thus causing significant shifting of spectral characteristics.
With this in mind we also compared the photophysical charac-
teristics of 1 and 2 with those of 4 and 5. The absorption spec-
trum of 4 showed a λmax at ca. 435 nm while that of 5 again
showed slightly shifted maxima at ca. 345 nm and 410 nm.
Emission from 4 (λexc = 435 nm) showed a λmax at 550 nm (ΦF =
0.64)31 while that of 5 (λexc = 345 nm) showed a λmax at 590 nm
(ΦF = 0.46),
31 again demonstrating a lower level of emission
when compared against the 4-substituted derivative. Indeed, it
was quickly noted when comparing the emission profiles of 1
and 4 that the shift in emission maxima was ca. 75 nm while
that of 2 and 5 was 130 nm. Satisfied with the observed spec-
tral variation between 1 and 4 and 2 and 5 we next investigated
their spectroscopic behaviour when placed under mimicked
reductive stress conditions by treatment with a type I NTR
(oxygen insensitive NTR expressed in E. coli).
Emission spectra were measured in PBS (pH 7.4, 10 mM)
with 0.5% DMSO as co-solvent in the presence of NADH
(50 µM, as a cofactor of NTR) at 25° C. Upon treatment of 1
with NTR a drastic, time dependant spectral change was
observed whereby a reduction in the emission maximum at
475 nm was accompanied by a concomitant increase in fluo-
rescence at 550 nm, clearly visible to the naked eye as a blue to
green colour change under UV irradiation (Fig. 2(a)). Over the
course of the 20 minutes experiment the fluorescence intensity
at 550 nm was increased by more than 8-fold while the emis-
sion at 475 nm had experienced a 5-fold decrease. The clear
fluorescence colour change from blue to green suggested suc-
cessful conversion of 1 to 4 as hypothesised in Fig. S8.†
Moreover, ESI-LCMS studies of 1 treated with NTR under the
same conditions confirmed the spectroscopic results above
where the MS spectrum revealed peaks at m/z = 269.13 and
291.11 attributed to the [M + H]+ and [M + Na]+ ions of 4
respectively (see ESI†). Interestingly, the same result was not
obtained for 2 which showed no fluorescence change when
treated with NTR under the same conditions while ESI-LCMS
only gave rise to peaks at m/z = 452.15 and 474.13 attributed to
the [M + H]+ and [M + Na]+ ions of the parent sensor 2, respect-
ively. Combined, these results suggest that, unlike 1, the
reduction of 2 does not proceed under these experimental con-
ditions. Similar experiments were carried out on the 4-nitro-
benzyl substituted probe NB which showed a considerably
weaker response to NTR undergoing approx. 30% decrease in
emission at 450 nm and a negligible increase at 550 nm when
Fig. 2 (a) Changes in the emission spectrum of 1 (10 µM) (λex 345 nm)
over 10 minutes at various time points after addition of NTR (1 µg mL−1)
(inset): fluorescence changes visible to the naked eye under UV light. (b)
Plots of the change in emission intensity at 545 nm as a function of time
after treatment with various concentrations of NTR in the presence of
NADH (50 µM).
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treated with the enzyme (see ESI†). These results suggest that
the 2-nitroimidazole moiety is considerably more prone to
enzymatic reduction than its 4-nitrobenzyl analogue and
points to a much more sensitive probe for NTR. This result is
particularly relevant given the focus of recent literature on
4-nitrobenzyl substituted fluorescent probes.10
Considering the above results, we chose to concentrate our
efforts on 1 where the release of 4 was also investigated in the
presence of different concentrations of NTR (0–5 µg mL−1) in
order to evaluate its sensitivity to the enzyme. As shown in
Fig. 2(b), higher concentrations of NTR resulted in a more
rapid increase in fluorescence intensity whereby treatment
with 5 µg mL−1 NTR resulted in almost 90% conversion to 4
after just 5 minutes at 25° C. Moreover, good linearity was
obtained over a wide concentration range of 0.02–5 μg mL−1
NTR, demonstrating a true ratiometric response of probe 1.
The emission measured from 1 in the absence of NTR
remained constant over the course of the experiment demon-
strating the stability of the probe under these mimicked bio-
logical conditions. Experiments over a range of pH values (pH
= 5–9) further demonstrated the applicability of probe 1 to a
biological environment whereby it was shown to perform best
at pH values consistent with those found in biological media
(7–8) (see ESI†). Tests on the specificity of the fluorescence
response were also evaluated in the presence of a number of
common biological interferents (NaCl, CaCl2, MgCl2, glucose,
H2O2, aspartic acid, lysine, serine, tyrosine, lysozyme) where
again probe 1 displayed a high level of both stability and
selectivity towards NTR over all of the other species tested.
These results taken collectively clearly establish that 1 can
respond to NTR in a ratiometric fashion, selectively and sensi-
tively, yielding a clear fluorescence change from blue to green,
visible to the naked eye. Having evaluated the spectroscopic
properties of 1 and its susceptibility to bioreduction we next
wished to evaluate 1 as a biological probe for reductive stress
in cellulo. The ability of 1 to be internalised in target cells was
first assessed via fluorescence confocal microscopy in cervical
cancer HeLa cells. Populations of live cells (0.5 × 105) were
incubated with 1 (10 µM) at 37 °C for 4 h. The results obtained
are exemplified in Fig. 3(a), which shows 1, upon successful
uptake into cells residing in a cytoplasmic location with a
strong emission of blue fluorescence. In contrast, reference
compound 4, under the same conditions, clearly exhibits
strong green emission also emanating from the cytoplasm.
The rate of uptake of compounds 1 and 4 into cells was also
investigated using flow cytometry where, again, both com-
pounds were shown to be rapidly taken up into cells, reaching
their maximum uptake within 15 min (Fig. 3(b)). 1 and 4 were
also taken up into cells when incubated at 4 °C for the dur-
ation of compound treatment (Fig. 3(c) and (d)) suggesting
passive diffusion to be the mechanism of uptake as endocyto-
sis, which requires ATP, is inhibited at this temperature. In
agreement with this, when cells were pre-treated with the
general endocytosis inhibitor dynasore, there was also no
effect on the uptake of 1 or 4 (Fig. 3(d)). Cellular viability in
the presence of 1 and 4 was also measured using an
AlamarBlue assay (Fig. 4(c)). Results showed that an IC50 value
could not be determined for 1, showing no observed toxicity
and similarly a modest IC50 value of 46 µM was observed for 4
when cells were treated for 24 h. Interestingly, compounds 2
and 5 were shown to have increased toxicity with IC50 values
of 7 µM and 35 µM, respectively, presumably due to their struc-
tural similarities to the known anti-proliferative agent amona-
fide.32 With the biological behaviour of 1 characterised we next
wished to evaluate its ability to monitor reductive stress in
cells. In order to mimic reductive stress on the cell population,
HeLa cells were treated with NTR (1 µg mL−1) and its co-factor
NADH (0.5 M) before addition of 1 or 2 (10 µM). Modulations
of fluorescence were then assessed using confocal microscopy.
Gratifyingly, after being subjected to such reduction con-
ditions, the emission from 1 was seen to rapidly change to
emission consistent with compound 4, suggesting successful
reduction of 1 to release 4 under these cell culture conditions
(Fig. 4(a)). The emission spectra of the compounds recorded
within cells demonstrated the λmax of 1 was 465 nm (range 410
to 595 nm), whilst the λmax of 4 was 512 nm (range 456 to
661 nm). Incubation of 1 under reducing conditions revealed a
cellular λmax of 512 nm (range 428 to 659 nm), again
suggesting successful reduction of 1 under these cell culture
conditions (Fig. 4(b)). The corresponding images and emission
spectra for 2 and reference compound 5 (see ESI†) show separ-
ate λmax values of 446 nm and 521 nm respectively, with no
Fig. 3 Uptake of 1 and 4 (10 µM) by HeLa cells measured by either con-
focal laser scanning microscopy or flow cytometry. (a) Cellular localis-
ation at 37 °C, (b) cellular uptake determined by flow cytometry (c) cel-
lular localisation at 4 °C and (d) passive diffusion and endocytosis deter-
mined by flow cytometry (scale bar = 10 µm).
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modulations upon subjection to reducing conditions; this sup-
ports the results of the enzymatic spectroscopic studies
described above which showed that treatment of 2 with NTR
did not release 5.
In summary, we have reported the synthesis of two 2-nitro-
imidazole-1,8-naphthalimide conjugates 1 and 2. Compound 1,
through a reduction–fragmentation mechanism, displays a
rapid, sensitive and selective ratiometric response to NTR,
clearly visible to the naked eye. In addition, we have demon-
strated the applicability of 1 to cellular detection of reductive
stress using both confocal microscopy and flow cytometry
where 1 allows facile discrimination of cells under normal con-
ditions and those under reductive stress. Considering the
recent observation of Hecht and co-workers that NTRs are
indeed prevalent in the mitochondria of A549 human lung
adenocarcinoma cells,33 the use of ratiometric probes for NTR
such as 1 will provide new perspectives on the role of reductive
stress in various diseases. We are actively pursuing this line of
research within our lab.
The authors wish to acknowledge Maynooth University and
Trinity College Dublin for Financial support. Prof. Thorri
Gunnlaugsson is acknowledged for his unwavering advice,
guidance and support.
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